Cross talk between stimulated NF-κB and the tumor suppressor p53
Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and trigg...
Gespeichert in:
Veröffentlicht in: | Oncogene 2010-05, Vol.29 (19), p.2795-2806 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2806 |
---|---|
container_issue | 19 |
container_start_page | 2795 |
container_title | Oncogene |
container_volume | 29 |
creator | Schneider, G Henrich, A Greiner, G Wolf, V Lovas, A Wieczorek, M Wagner, T Reichardt, S von Werder, A Schmid, R M Weih, F Heinzel, T Saur, D Krämer, O H |
description | Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins. |
doi_str_mv | 10.1038/onc.2010.46 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2641403982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A227198367</galeid><sourcerecordid>A227198367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</originalsourceid><addsrcrecordid>eNptkM1OAyEUhYnRxFpd-QIkxpVOZfgbWNbGqkmjm-4JwzB16vwJTIyv5kP4TNK0sTFpWFwufOdcOABcpmiSIiLuutZMMIod5UdglNKMJ4xJegxGSDKUSEzwKTjzfo0QyiTCIzCduc57GHT9DnMbPq1toQ9VM9Q62AK-zJOf73uo2wKGNwvD0HQO-qHvnfU-bntGzsFJqWtvL3Z1DJbzh-XsKVm8Pj7PpovEUIJDohGWJSviYI6FidMFLSQl3HKaIiQNK3EuLE4Z5lIInfOcaoZSSzDLRSxjcLW17V33MVgf1LobXBsnKhwtKCJS4D210rVVVVt2wWnTVN6oKcZZKgXhWaQmB6i4CttUpmttWcXzf4KbrcBs0nK2VL2rGu2-VIrUJnkVk1eb5BXlkb7ePVV7o-vS6dZU_k8SbQXOCIrc7Zbz8apdWbf_0iHbX9hKjlQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641403982</pqid></control><display><type>article</type><title>Cross talk between stimulated NF-κB and the tumor suppressor p53</title><source>Springer Nature - Complete Springer Journals</source><source>Nature</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Schneider, G ; Henrich, A ; Greiner, G ; Wolf, V ; Lovas, A ; Wieczorek, M ; Wagner, T ; Reichardt, S ; von Werder, A ; Schmid, R M ; Weih, F ; Heinzel, T ; Saur, D ; Krämer, O H</creator><creatorcontrib>Schneider, G ; Henrich, A ; Greiner, G ; Wolf, V ; Lovas, A ; Wieczorek, M ; Wagner, T ; Reichardt, S ; von Werder, A ; Schmid, R M ; Weih, F ; Heinzel, T ; Saur, D ; Krämer, O H</creatorcontrib><description>Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/onc.2010.46</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/250/516/1909 ; 631/67/581 ; 631/80/86 ; 692/699/67 ; Ageing, cell death ; Apoptosis ; Ataxia ; Biological and medical sciences ; Cell Biology ; Cell physiology ; Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes ; Cytosol ; Fundamental and applied biological sciences. Psychology ; Gene expression ; Genetic aspects ; Health aspects ; Human Genetics ; Inflammation ; Internal Medicine ; Kinases ; Medicine ; Medicine & Public Health ; Molecular and cellular biology ; Molecular modelling ; NF-κB protein ; Oncology ; original-article ; p53 Protein ; Physiological aspects ; Regulatory sequences ; Risk factors ; Transcription factors ; Tumor necrosis factor ; Tumor necrosis factor-TNF ; Tumor necrosis factor-α ; Tumor suppressor genes ; Tumorigenesis ; Tumors</subject><ispartof>Oncogene, 2010-05, Vol.29 (19), p.2795-2806</ispartof><rights>Macmillan Publishers Limited 2010</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 Nature Publishing Group</rights><rights>Macmillan Publishers Limited 2010.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</citedby><cites>FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/onc.2010.46$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/onc.2010.46$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22782730$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, G</creatorcontrib><creatorcontrib>Henrich, A</creatorcontrib><creatorcontrib>Greiner, G</creatorcontrib><creatorcontrib>Wolf, V</creatorcontrib><creatorcontrib>Lovas, A</creatorcontrib><creatorcontrib>Wieczorek, M</creatorcontrib><creatorcontrib>Wagner, T</creatorcontrib><creatorcontrib>Reichardt, S</creatorcontrib><creatorcontrib>von Werder, A</creatorcontrib><creatorcontrib>Schmid, R M</creatorcontrib><creatorcontrib>Weih, F</creatorcontrib><creatorcontrib>Heinzel, T</creatorcontrib><creatorcontrib>Saur, D</creatorcontrib><creatorcontrib>Krämer, O H</creatorcontrib><title>Cross talk between stimulated NF-κB and the tumor suppressor p53</title><title>Oncogene</title><addtitle>Oncogene</addtitle><description>Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.</description><subject>631/250/516/1909</subject><subject>631/67/581</subject><subject>631/80/86</subject><subject>692/699/67</subject><subject>Ageing, cell death</subject><subject>Apoptosis</subject><subject>Ataxia</subject><subject>Biological and medical sciences</subject><subject>Cell Biology</subject><subject>Cell physiology</subject><subject>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</subject><subject>Cytosol</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Human Genetics</subject><subject>Inflammation</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Molecular and cellular biology</subject><subject>Molecular modelling</subject><subject>NF-κB protein</subject><subject>Oncology</subject><subject>original-article</subject><subject>p53 Protein</subject><subject>Physiological aspects</subject><subject>Regulatory sequences</subject><subject>Risk factors</subject><subject>Transcription factors</subject><subject>Tumor necrosis factor</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumor necrosis factor-α</subject><subject>Tumor suppressor genes</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkM1OAyEUhYnRxFpd-QIkxpVOZfgbWNbGqkmjm-4JwzB16vwJTIyv5kP4TNK0sTFpWFwufOdcOABcpmiSIiLuutZMMIod5UdglNKMJ4xJegxGSDKUSEzwKTjzfo0QyiTCIzCduc57GHT9DnMbPq1toQ9VM9Q62AK-zJOf73uo2wKGNwvD0HQO-qHvnfU-bntGzsFJqWtvL3Z1DJbzh-XsKVm8Pj7PpovEUIJDohGWJSviYI6FidMFLSQl3HKaIiQNK3EuLE4Z5lIInfOcaoZSSzDLRSxjcLW17V33MVgf1LobXBsnKhwtKCJS4D210rVVVVt2wWnTVN6oKcZZKgXhWaQmB6i4CttUpmttWcXzf4KbrcBs0nK2VL2rGu2-VIrUJnkVk1eb5BXlkb7ePVV7o-vS6dZU_k8SbQXOCIrc7Zbz8apdWbf_0iHbX9hKjlQ</recordid><startdate>20100513</startdate><enddate>20100513</enddate><creator>Schneider, G</creator><creator>Henrich, A</creator><creator>Greiner, G</creator><creator>Wolf, V</creator><creator>Lovas, A</creator><creator>Wieczorek, M</creator><creator>Wagner, T</creator><creator>Reichardt, S</creator><creator>von Werder, A</creator><creator>Schmid, R M</creator><creator>Weih, F</creator><creator>Heinzel, T</creator><creator>Saur, D</creator><creator>Krämer, O H</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20100513</creationdate><title>Cross talk between stimulated NF-κB and the tumor suppressor p53</title><author>Schneider, G ; Henrich, A ; Greiner, G ; Wolf, V ; Lovas, A ; Wieczorek, M ; Wagner, T ; Reichardt, S ; von Werder, A ; Schmid, R M ; Weih, F ; Heinzel, T ; Saur, D ; Krämer, O H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-a029f5d000628c07984d9436e641009c5f2b8e21526988ab6b4a501e325b81e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>631/250/516/1909</topic><topic>631/67/581</topic><topic>631/80/86</topic><topic>692/699/67</topic><topic>Ageing, cell death</topic><topic>Apoptosis</topic><topic>Ataxia</topic><topic>Biological and medical sciences</topic><topic>Cell Biology</topic><topic>Cell physiology</topic><topic>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</topic><topic>Cytosol</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Human Genetics</topic><topic>Inflammation</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Molecular and cellular biology</topic><topic>Molecular modelling</topic><topic>NF-κB protein</topic><topic>Oncology</topic><topic>original-article</topic><topic>p53 Protein</topic><topic>Physiological aspects</topic><topic>Regulatory sequences</topic><topic>Risk factors</topic><topic>Transcription factors</topic><topic>Tumor necrosis factor</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumor necrosis factor-α</topic><topic>Tumor suppressor genes</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, G</creatorcontrib><creatorcontrib>Henrich, A</creatorcontrib><creatorcontrib>Greiner, G</creatorcontrib><creatorcontrib>Wolf, V</creatorcontrib><creatorcontrib>Lovas, A</creatorcontrib><creatorcontrib>Wieczorek, M</creatorcontrib><creatorcontrib>Wagner, T</creatorcontrib><creatorcontrib>Reichardt, S</creatorcontrib><creatorcontrib>von Werder, A</creatorcontrib><creatorcontrib>Schmid, R M</creatorcontrib><creatorcontrib>Weih, F</creatorcontrib><creatorcontrib>Heinzel, T</creatorcontrib><creatorcontrib>Saur, D</creatorcontrib><creatorcontrib>Krämer, O H</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, G</au><au>Henrich, A</au><au>Greiner, G</au><au>Wolf, V</au><au>Lovas, A</au><au>Wieczorek, M</au><au>Wagner, T</au><au>Reichardt, S</au><au>von Werder, A</au><au>Schmid, R M</au><au>Weih, F</au><au>Heinzel, T</au><au>Saur, D</au><au>Krämer, O H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cross talk between stimulated NF-κB and the tumor suppressor p53</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><date>2010-05-13</date><risdate>2010</risdate><volume>29</volume><issue>19</issue><spage>2795</spage><epage>2806</epage><pages>2795-2806</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><abstract>Nuclear factor-κB (NF-κB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-κB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-κB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on κB response elements. Gene expression analyses revealed that, independent of NF-κB activation in the cytosol, TNF-induced NF-κB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-κB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-κB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/onc.2010.46</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0950-9232 |
ispartof | Oncogene, 2010-05, Vol.29 (19), p.2795-2806 |
issn | 0950-9232 1476-5594 |
language | eng |
recordid | cdi_proquest_journals_2641403982 |
source | Springer Nature - Complete Springer Journals; Nature; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | 631/250/516/1909 631/67/581 631/80/86 692/699/67 Ageing, cell death Apoptosis Ataxia Biological and medical sciences Cell Biology Cell physiology Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes Cytosol Fundamental and applied biological sciences. Psychology Gene expression Genetic aspects Health aspects Human Genetics Inflammation Internal Medicine Kinases Medicine Medicine & Public Health Molecular and cellular biology Molecular modelling NF-κB protein Oncology original-article p53 Protein Physiological aspects Regulatory sequences Risk factors Transcription factors Tumor necrosis factor Tumor necrosis factor-TNF Tumor necrosis factor-α Tumor suppressor genes Tumorigenesis Tumors |
title | Cross talk between stimulated NF-κB and the tumor suppressor p53 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T23%3A29%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cross%20talk%20between%20stimulated%20NF-%CE%BAB%20and%20the%20tumor%20suppressor%20p53&rft.jtitle=Oncogene&rft.au=Schneider,%20G&rft.date=2010-05-13&rft.volume=29&rft.issue=19&rft.spage=2795&rft.epage=2806&rft.pages=2795-2806&rft.issn=0950-9232&rft.eissn=1476-5594&rft_id=info:doi/10.1038/onc.2010.46&rft_dat=%3Cgale_proqu%3EA227198367%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2641403982&rft_id=info:pmid/&rft_galeid=A227198367&rfr_iscdi=true |